AbbVie vs Burlington: Founders, CEOs and History
AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. Burlington was founded in 1972 by Monroe Milstein and is led by Michael O'Sullivan.
Company facts
AbbVie
- Founded
- 2013
- Headquarters
- North Chicago, Illinois
- Current CEO
- Robert A. Michael
- Employees
- 57,000
Burlington
- Founded
- 1972
- Headquarters
- Burlington, New Jersey
- Current CEO
- Michael O'Sullivan
- Employees
- 83,309
Founders
AbbVie
Abbott Laboratories (spin-off origin)
Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.
Burlington
Monroe Milstein
Monroe G. Milstein grew up in his family's wholesale outerwear business in New York.
CEOs and their tenures
AbbVie
- Richard A. Gonzalez2013–2024
Founding Chairman and Chief Executive Officer
Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.
Source - Robert A. Michael2024–present
Chairman and Chief Executive Officer
Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.
Source
Burlington
- Monroe Milstein1972–2006
Founder and Chief Executive Officer
Milstein opened the first Burlington Coat Factory in Burlington, New Jersey, in 1972, broadened it from discount coats into year-round family apparel, shoes, baby and home goods, and took it public in 1983.
Source - Mark Nesci2006–2008
Chief Executive Officer
A 37-year Burlington veteran, Nesci became CEO in 2006 after Bain Capital took the company private for about $2.06 billion. He retired in December 2008, remaining an equity investor and senior adviser to the board.
Source - Tom Kingsbury2008–2019
President and Chief Executive Officer
A former Kohl's senior executive, Kingsbury was hired by Bain Capital in December 2008 to revamp buying, inventory management and the supply chain.
Source - Michael O'Sullivan2019–present
Chief Executive Officer
O'Sullivan joined from Ross Stores, where he spent 16 years and finished as president and COO, and became CEO around September 16, 2019.
Source
Timeline: AbbVie and Burlington side by side
1972Burlington
Burlington Coat Factory opens
Monroe Milstein bought a coat outlet in a former factory building in Burlington, New Jersey, and sold brand-name coats at discount prices, the start of Burlington Coat Factory.
1983Burlington
First public offering
Burlington Coat Factory Warehouse Corporation went public for the first time, funding expansion from a regional discounter into a national chain with year-round apparel, shoes, baby and home departments.
1989Burlington
Cohoes Specialty Stores acquired
Burlington bought the Cohoes Specialty Stores off-price chain from upstate New York, including a 50 percent stake in the Cohoes Commons building; a few stores still traded as Cohoes Fashions decades later.
2006Burlington
Bain Capital takes Burlington private
Bain Capital acquired Burlington Coat Factory for about $2.06 billion, ending 34 years of Milstein family control. Long-time executive Mark Nesci became chief executive.
2008Burlington
Tom Kingsbury named CEO
Former Kohl's executive Thomas Kingsbury became president and CEO in December 2008, succeeding Mark Nesci, and began overhauling buying, inventory management and the supply chain.
2013AbbVie
AbbVie Launches as an Independent Company
AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.
2013Burlington
Return to the stock market
Burlington Stores priced its IPO on October 2, 2013, selling 13.3 million shares at $17 each for about $226 million, and listed under the ticker BURL.
2015AbbVie
Pharmacyclics Acquisition Completed
AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.
2019AbbVie
Skyrizi Receives Initial U.S. Approval
The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.
2019AbbVie
Rinvoq Receives Initial U.S. Approval
The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.
2019Burlington
Michael O'Sullivan becomes CEO
Former Ross Stores president and COO Michael O'Sullivan succeeded Tom Kingsbury as CEO around September 16, 2019, and later launched the Burlington 2.0 plan of leaner inventories and smaller stores.
2020AbbVie
Allergan Acquisition Completed
AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.
2020Burlington
Online sales end and stores close for the pandemic
On March 5, 2020, Burlington said it would shut its e-commerce business. Days later pandemic lockdowns closed its stores, and fiscal 2020 revenue fell to $5.76 billion with a $216.5 million net loss.
2023AbbVie
U.S. Humira Biosimilar Competition Begins
Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.
2023Burlington
Bed Bath & Beyond leases
Burlington won 44 Bed Bath & Beyond leases for $12 million at the June 2023 bankruptcy auction, the largest share of the 109 sold, and later reported 62 former Bed Bath & Beyond leases in total.
2024AbbVie
ImmunoGen Acquisition Completed
AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.
2024AbbVie
Robert A. Michael Becomes CEO
Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.
2024AbbVie
Cerevel Therapeutics Acquisition Completed
AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.
2025AbbVie
Robert A. Michael Becomes Chairman
Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.
2025AbbVie
FY2025 Revenue Reaches $61.160 Billion
AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.
2025Burlington
Joann leases
After Joann's second bankruptcy, Burlington agreed in April 2025 to take over 45 Joann store leases, many of which became part of its fiscal 2026 opening program.
2026AbbVie
Q1 2026 Revenue Reaches $15.002 Billion
AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.
2026Burlington
Record fiscal 2025 results
Burlington reported fiscal 2025 total revenue of $11.57 billion and net income of $610.2 million, and ended the year on January 31, 2026, with 1,212 stores.
2026Burlington
Tariff refunds put into prices
In the second quarter of fiscal 2026, sales rose 11 percent to $2.998 billion. Burlington received $55 million in tariff refunds and said it would reinvest them in lower prices; the store count reached 1,287.
2026Burlington
Headquarters move to Philadelphia announced
On September 3, 2026, Burlington said it will invest $370 million to move its headquarters from Burlington Township, New Jersey, to Schuylkill Yards in Philadelphia, in phases from late 2028 or early 2029.
Acquisitions
AbbVie
- ImmunoGen, Inc.2024$10.1B
- Cerevel Therapeutics2024$8.7B
- Allergan plc2020$63B
- Pharmacyclics, Inc.2015$21B
Burlington
- Joann store leases2025Undisclosed
- Bed Bath & Beyond store leases2023$12M
- Burlington Coat Factory (taken private by Bain Capital)2006$2.1B
- Cohoes Specialty Stores (Cohoes Fashions)1989Undisclosed
Questions about AbbVie vs Burlington
Who is the CEO of AbbVie Inc. and Burlington Stores, Inc.?
AbbVie Inc. is led by Robert A. Michael and Burlington Stores, Inc. is led by Michael O'Sullivan. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AbbVie Inc. founded vs Burlington Stores, Inc.?
Burlington Stores, Inc. was founded in 1972 — 41 years before AbbVie Inc., which was founded in 2013. Burlington Stores, Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..
How many employees does AbbVie Inc. have compared to Burlington Stores, Inc.?
AbbVie Inc. employs approximately 57,000 people, while Burlington Stores, Inc. employs approximately 83,309. Burlington Stores, Inc. has the larger workforce at 83,309 employees, compared to AbbVie Inc.'s 57,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AbbVie Inc. and Burlington Stores, Inc. headquartered?
Both AbbVie Inc. and Burlington Stores, Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded AbbVie Inc. and Burlington Stores, Inc.?
AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). Burlington Stores, Inc. was founded by Monroe Milstein.
Which company has a longer operating history — AbbVie Inc. or Burlington Stores, Inc.?
Burlington Stores, Inc. has been operating for approximately 54 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs Burlington overview